Scrip Symbol

KAYNES

Key Quantitative Figures

First Qualified Institutional Placement (December 21, 2023):

  • Gross Issue Proceeds: ₹14,000 million
  • Issue Expenses: ₹260 million
  • Net Amount Transferred to Monitoring Agency: ₹13,740 million
  • Funds Utilized: ₹13,488 million
  • Unutilized Funds: Deposited as fixed deposits with Canara Bank and Federal Bank

Second Qualified Institutional Placement (June 24, 2025):

  • Gross Issue Proceeds: ₹16,000 million
  • Issue Expenses: ₹250.34 million
  • Balance in Public Issue Account: ₹0.09 million
  • Net Amount Transferred to Monitoring Agency: ₹15,749.66 million
  • Funds Utilized: ₹15,740.58 million
  • Unutilized Funds: Deposited in investments as permitted under applicable laws and company's Investment Policy

Detailed Fund Utilization Breakdown

December 2023 QIP (Monitored by ICRA Limited):

  • Funding of establishment of the Part cost of PCB facility: ₹11,567.77 million allocated, ₹7,315.55 million utilized
  • Establishment of the Part cost of PCB facility: ₹9,728.30 million allocated, ₹3,072.89 million utilized
  • General corporate purposes: ₹3,100.00 million allocated, ₹3,100.00 million utilized

June 2025 QIP (Monitored by CRISIL Ratings Limited):

  • Funding of working capital requirements and repayment of debt: ₹18,412.60 million allocated and fully utilized
  • General corporate purposes including growth opportunities: ₹2,000.00 million allocated, ₹200.00 million utilized
  • General corporate purposes including inorganic growth: ₹1,600.00 million allocated, ₹1,600.00 million utilized
  • General corporate purposes: ₹3,737.05 million allocated, ₹3,327.93 million utilized

Dates of Action

  • Quarter ended: June 30, 2026
  • Audit Committee and Board review date: August 07, 2026
  • First QIP allotment date: December 21, 2023
  • Second QIP allotment date: June 24, 2025

Parties Involved

  • Monitoring Agency for December 2023 QIP: ICRA Limited
  • Monitoring Agency for June 2025 QIP: CRISIL Ratings Limited
  • Company Secretary and Compliance Officer: Sudhasri Addepalli (ICSI Membership No. ACS 79832)
  • Whole Time Director & CFO: Jairam P Sampath (DIN: 08064368)

Financial Impact

No deviations or variations reported in fund utilization. All unutilized funds are properly deposited as per regulatory requirements.

Additional Information

The disclosure statement was reviewed by the Audit Committee and Board of Directors at their meeting held on August 07, 2026. No comments were received from the auditors regarding the fund utilization. The information is also available on the company's website at www.kaynestechnology.co.in.